Suzy Lisa
Senior Vice President, Investor Relations
Replay available
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q2 2025 earnings conference call, held 2025-08-04. Replay captured from the company's public earnings webcast.

Senior Vice President, Investor Relations
Chief Executive Officer and President
Chief Commercial Officer
Chief Operating and Financial Officer
Analyst, JPMorgan
Analyst, Goldman Sachs
Analyst, Citibank
Analyst, UBS
Watch the replay and follow the connected company analysis, news, and investor updates for Vertex Pharmaceuticals Incorporated.
WEBVTT 00:00:00.031 -- 00:00:05.737 Good day and welcome to the Vertex Pharmaceuticals second quarter 2025 earnings call. 00:00:05.737 -- 00:00:08.199 All participants will be in a listen-only mode. 00:00:08.199 -- 00:00:11.703 Should you need assistance, please signal a conference specialist by pressing the star 00:00:11.703 -- 00:00:16.668 key followed by zero. After today's presentation, there will be an opportunity to ask 00:00:16.668 -- 00:00:21.893 questions. To ask a question, you may press star, then one on a touch-tone phone. 00:00:21.893 -- 00:00:25.016 To withdraw your question, please press star, then two. 00:00:25.016 -- 00:00:27.807 Please note that this event is being recorded. 00:00:27.807 -- 00:00:30.551 I would now like to turn the conference over to Suzy Lisa. 00:00:30.551 -- 00:00:31.853 Please go ahead, ma'am. 00:00:31.853 -- 00:00:35.878 Good evening, all. My name is Suzy Lisa, and as the Senior Vice President of Investor 00:00:35.878 -- 00:00:40.825 Relations, it is my pleasure to welcome you to our second quarter 2025 Financial Results 00:00:40.825 -- 00:00:44.390 Conference Call. On tonight's call, making prepared remarks, we have Dr. 00:00:44.390 -- 00:00:49.998 Reshma Kewalramani, Vertex's CEO and President, Duncan McKechnie, Chief Commercial Officer, 00:00:49.998 -- 00:00:53.002 and Charlie Wagner, Chief Operating and Financial Officer. 00:00:53.002 -- 00:00:56.748 We recommend that you access the webcast slides as you listen to this call. 00:00:56.748 -- 00:01:00.375 The call is being recorded and a replay will be available on our website. 00:01:00.375 -- 00:01:04.442 We will make forward-looking statements on this call that are subject to the risks and 00:01:04.442 -- 00:01:08.809 uncertainties discussed in detail in today's press releas...